Company page

Medite Cancer Diagnostics Inc

Medite Cancer Diagnostics Inc (MDIT) is a public company based in the United States, focused on developing innovative diagnostic solutions for cancer detection. With a market capitalization of approximately $8.62 billion, Medite aims to improve patient outcomes through advanced technology and research in the field of cancer diagnostics. The company is committed to providing reliable and accurate diagnostic tools to healthcare professionals.

profileMDITAI content: aiUpdated May 29, 2026/company/medite-cancer-diagnostics-inc
Medite Cancer Diagnostics Inc logo
Ticker
MDIT
Market cap
$8,620
Sector
Health Technology
Industry
Medical Specialties